Ventricular Assist Device Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Ventricular Assist Device Market
The ventricular assist device market size was reached at a value of USD 1.25 billion in 2023, and the market is now projected to grow from USD 1.36 billion in 2024 to USD 2.88 billion by 2032, exhibiting a CAGR of 9.9% during the forecast period of 2023-2030.
The COVID-19 epidemic delayed non-emergency procedures, leading to fewer VAD transplants. Furthermore, supply chain interruptions had an impact on market growth. In 2021, the market saw tremendous growth compared to the previous year. The relaxation of lockdown limitations led to an increase in cardiologist appointments.
Due to increasing prevalence of heart failure, the demand for ventricular assist device is increasing. Heart failure is becoming one of the prominent causes of death affecting large population propelling ventricular assist device market growth. Aged population is more prone to illness and contribute a greater number of heart failure. Mechanical circulatory support devices such as total artificial heart, extracorporeal membrane oxygenator pumps, VAD, and Intra-aortic balloon pumps used to assist cardiac circulation when medications are not effective. To meet the growing demand for VAD, market participants are launching new products and expanding manufacturing capacity.
Additionally, due to increasing technological developments for mechanical circulatory support systems the market is leading expansion. Advancements in healthcare technology enable healthcare workers to record and monitor clinical data with minimum errors using artificial intelligence. The risk of cardiovascular illness can be determined by artificial intelligence, which can later be utilized to improve risk of prediction and better treatment options for patients. It can also be used during procedures to examine the patient's anatomy, risk factors, medical history, and other aspects that can improve surgery outcomes.
Comprehensive Analysis of Ventricular Assist Device Market
The ventricular assist device market is rising with an exponential rate due to its versatile market segmentation. This market expansion effectively provides a detailed geographical assessment considering the dominant supply and demand forces that impact the ventricular assist device management industry. These segmentations are methodically segregated by types of products, type of flow, type of application and by end users. The types of Product segment include Left Ventricular Assist Device, Right Ventricular Assist Device, and Bi-Ventricular Assist Device, and By Type of Flow segment include Pulsatile Flow and Continuous Flow), while By Application segment include Bridge to Transplant (BTT), Bridge to Candidacy (BTC), Destination Therapy (DT), and Bridge to Recovery (BTR)). However, By End-user segment include Hospitals & ASCs and Specialty Clinics & Others.
In the ventricular assist device market, North America region lead the healthcare devices market by benefitting a market size of USD 0.64 billion in 2023 owing to robust healthcare infrastructure and adoption of advanced medical technologies and rising prevalence of cardiovascular illness.
The prominent players in the market play a crucial role in the ventricular assist device industry assuring industrial prospectus growth and setting market standards. These players include, Berlin Heart (Germany), ABIOMED (U.S.), Abbott (U.S.) and Jarvik Heart, Inc. (U.S.) these prominent market players provide a level-playing competitive environment across the globe.
In November 2022, Jarvik Heart, Inc. conducted a clinical trial for their ventricular assist device, Jarvik 2015, in order to strengthen their product line.
Segmentation Table
Attribute Details
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 9.9% over 2024 to 2032
Unit Value (USD million)
Segmentation
By Product
Left Ventricular Assist Device
Right Ventricular Assist Device
Bi-Ventricular Assist Device
By Type of Flow
Pulsatile Flow
Continuous Flow
By Application
Bridge to Transplant (BTT)
Bridge to Candidacy (BTC)
Destination Therapy (DT)
Bridge to Recovery (BTR)
By End-user
Hospitals & ASCs
Specialty Clinics & Others
By Geography
- North America (By Product, By Type of Flow, By Application, and By Country)
- U.S. (By Product)
- Canada (By Product)
Europe (By Product, By Type of Flow, By Application, and By Country)
- U.K. (By Product)
- Germany (By Product)
- France (By Product)
- Italy (By Product)
- Spain (By Product)
- Rest of Europe (By Product)
- Asia Pacific (By Product, By Type of Flow, By Application, and By Country) China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
- Latin America (By Product, By Type of Flow, By Application, and By Country)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
- Middle East & Africa (By Product, By Type of Flow, By Application, and By Country)
- GCC (By Product)
- South Africa (By Product)
- Rest of the Middle East & Africa (By Product)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.